GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75F40122C00182UNIVERSITY OF FLORIDA

Overview

Award facts

Net obligations
$1.84M
$1,844,289of $1.84M potential value
Outlays (paid to date)
$1.54M
$1.54M paid of $1.84M obligated$1,537,577
Period of performance
Sep 21, 2022 to Sep 29, 2026
Ended
Modifications
2
Latest action Jan 17, 2025
Contract type
Definitive contract
PIID 75F40122C00182

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

ADVANCING IN VITRO AND (PATHO)PHYSIOLOGY-BASED PHARMACOKINETICS MODELS TO UNDERSTAND AND PREDICT PULMONARY ABSORPTION AND TISSUE RETENTION OF INHALED DRUGS

Dates and value

Award date
Signed on Sep 21, 2022
Potential end of performance
Sep 28, 2026
Current value
$1,844,289Base and exercised options
Potential value (if all options are exercised)
$1,844,289

Obligations by fiscal year of action

  • FY2022: $1,844,289

Total across 1 fiscal year: $1,844,289

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 17, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationGAINESVILLE, FL
UEINNFQH1JAPEP3
CAGE code5E687
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity
Parent companyUNIVERSITY OF FLORIDA

Business types and certifications

Educational institutionU.S. government entity

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Cures activities; Fda user fees (non general fund)Program activities075-0600, 075-5629Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Montgomery County, Maryland 20993-0003
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Basic researchBR
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
1

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 21, 2022Base obligation at award: $1,844,289
Latest action
Jan 17, 2025 — Other administrative actionModification P00002; administrative: no change in scope or value
Actions by type
  • Base award1
  • Other administrative action1
  • Vendor identifier change (novation)1
3 actions recorded, Sep 21, 2022 to Jan 17, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
Other U.S. entity (e.g. government)B
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
3

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-X-0600-000
  • 075-X-5629-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression